MedPage Today on MSN5d
GLP-1 Spending Hit $5.8 Billion in 2022 for U.S. Adults Without Diabetes
The number of U.S. adults without diabetes using GLP-1 receptor agonists more than tripled from 2018 to 2022, boosting annual ...
Healio1d
Use of GLP-1 agonists prior to THA may increase postoperative nausea, vomiting
GLP-1 agonists may lead to increased nausea and vomiting in the early postoperative period after total hip arthroplasty, ...
Managed Healthcare Executive3d
GLP-1 Side Effects Have a Side Effect on Pharmacy Costs| AMCP Annual 2025
Researchers say payers should take the added costs of drugs prescribed to deal with GLP-1 side effects into account when ...
UPI4d
Costly GLP-1 drug use for weight loss has soared, study reports
The number of people without diabetes taking a GLP-1 drug more than tripled between 2018 and 2022 in the United States, researchers reported Monday in the Annals of Internal Medicine ...